Alzheimer’s disease and dementia represent significant challenges in healthcare, affecting millions worldwide. Alzheimer’s, the most common form of dementia, progressively impairs memory and cognitive functions, often leading to behavioral changes and an inability to perform daily tasks. The disease is characterized by the accumulation of plaques and tangles in the brain, disrupting neuronal communication and causing brain cells to degenerate and die.
Symptoms typically worsen over time, severely impacting quality of life and requiring extensive caregiving. While age is the greatest risk factor, Alzheimer’s can also affect younger individuals in rare cases. Current treatments aim to manage symptoms rather than cure the disease, highlighting the urgent need for research into effective therapies and prevention strategies. As populations age globally, addressing Alzheimer’s and dementia remains a critical priority in public health and medical research.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States